From extending lifespan to bolstering the immune system, the drug’s effects are only just beginning to be understood.
Early-stage melanoma cells alter proteins in nearby skin cells to create a favorable environment for cancer progression.
March 20, 2017|
DEPARTMENT OF DERMATOLOGY, UNIVERSITY HOSPITAL ERLANGEN, TRANSLATIONAL RESEARCH CENTER, GERMANY
(See C. Ostalecki et al., “Multiepitope tissue analysis reveals SPPL3-mediated ADAM10 activation as a key step in the transformation of melanocytes,” Science, doi:10.1126/scisignal.aai8288, 2017.)